The First Cannabis Drug to Earn FDA Breakthrough Therapy Status for Pain`
The FDA has granted Breakthrough Therapy Designation to VER-01, a full-spectrum cannabis extract, after two Phase 3 RCTs showed significant pain reduction in patients with chronic low back pain. VER-01 outperformed opioids on both pain relief and…
CBD Increases Food Intake in Controlled Human Trial
This clinical trial on CBD appetite regulation reveals that cannabidiol increases food intake in healthy adults. Despite lower ghrelin levels, participants consumed more calories, challenging previous assumptions. These findings highlight the complexity…
Reclassification of marijuana opens doors for much-needed medical research into the … – Seattle PI
The potential reclassification of cannabis from Schedule I to Schedule III could significantly reduce medical research barriers that have limited clinical evidence generation for decades. This regulatory shift would maintain federal oversight while…
US DEA medical marijuana registration portal to launch Wednesday – Virginia Lawyers Weekly
The DEA's new medical marijuana registration portal requirements represent a significant shift in federal cannabis oversight for healthcare providers. This centralized system could streamline physician access while establishing clearer regulatory…
Marijuana research may reach new heights as Trump Administration reclassifies medical cannabis
The potential reclassification of cannabis to Schedule III could revolutionize medical research by removing decades-old barriers to rigorous clinical studies. This cannabis schedule III reclassification research impact represents a historic opportunity…
Cannabinoids and drug-drug pharmacokinetic interactions: Deciphering the risks.
A new review in the British Journal of Clinical Pharmacology examines cannabinoid drug interactions clinical monitoring requirements. The analysis highlights the need for systematic assessment of cannabis use when prescribing medications. Healthcare…
Modulating the endocannabinoid system in alcohol use disorder: A translational systematic review and meta-analysis of preclinical and human studies.
A comprehensive systematic review examining CBD alcohol use disorder treatment potential found that CBD consistently reduced alcohol consumption in preclinical studies. However, human clinical data remains insufficient to support treatment…
Associations Between Cannabis Use and Inflammatory Biomarkers Among People with HIV.
A new cohort study found associations between current cannabis use and lower inflammatory biomarkers in people with HIV on antiretroviral therapy. While the cannabis inflammatory biomarkers HIV patients research is intriguing, the cross-sectional design…
Cannabis & Dental Care
Clinical Relevance #62 Emerging but Limited Evidence Mechanistic promise exists, but clinical translation remains early and uncertain. Clinical Insight Cannabis in dentistry is biologically plausible but clinically immature. The key risk is…
Unveiling Neurological Benefits: A Review of Hemp Leaf, Flower, Seed Oil Extract, and Their Phytochemical Properties in Neurological Disorders.
A new review examines hemp extract neurological disorders research, analyzing potential therapeutic applications for epilepsy, Alzheimer's, and Parkinson's disease. This clinical analysis explores what the evidence shows and doesn't show about…